Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|February 7, 2012
6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent mannerNikola Kotur, Biljana Stankovic, Katerina Kassela, et al.
International Journal of Molecular Sciences|May 11, 2016
Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing AnalysesMilena Todorovic Balint, Jelena Jelicic, Biljana Mihaljevic, et al.
Pharmacogenomics|April 6, 2013
Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacyChristina Tafrali, Arsinoi Paizi, Joseph Borg, et al.
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Human Genomics|November 13, 2016
Novel genetic risk variants for pediatric celiac diseaseAngeliki Balasopoulou, Biljana Stanković, Angeliki Panagiotara, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
Plos One|February 17, 2017
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Pageof 14